Clinical Trial Update: Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

View source ↗

Summary

This completed observational safety study evaluated the safety of an adjuvanted Swine Origin A(H1N1) pandemic subunit egg-derived vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza

Drugs mentioned

• Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Pandemic Influenza A (H1N1), A New Flu Virus of Swine Origin | Status: COMPLETED